Target intelligence / Profile preview

Serine dehydratase-like (SDSL)

Target
SDSL
Molecular classification
Enzyme, Lyase, Pyridoxal phosphate (PLP)-dependent enzyme, Ammonia-lyase
01

Overview

Serine dehydratase-like (SDSL) is a human enzyme encoded by the SDSL gene, closely related to serine dehydratase (SDH) enzymes. It catalyzes the pyridoxal-phosphate-dependent dehydrative deamination of L-serine to pyruvate and ammonia and can also act on L-threonine and L-/D-glutamate[2][5]. SDSL plays an important role in amino acid catabolism, particularly in gluconeogenesis and amino acid metabolism pathways. The enzyme is a member of the β-family of PLP-dependent lyases and contains a PALP domain[2][5]. SDSL is implicated in cancer biology, as alterations in its activity or expression are observed in tumorous tissues, and may also influence metabolic disorders associated with amino acid imbalance[1][2]. Its main known physiological cofactor is pyridoxal phosphate. Known inhibitors include several amino acids and metabolic intermediates, and the enzyme is subject to hormonal regulation in the liver[1]. Little is known about human SDSL function specifically due to low enzymatic activity in the human liver; its best-studied function is in model organisms and metabolic studies.

Other names
Cancerous serine dehydratasecSDHGlutamate racemaseL-serine deaminaseL-serine dehydratase/L-threonine deaminaseL-threonine dehydrataseSerine dehydratase 2SDH 2SDHLSDS-RS1TDH
02

Mechanism of action

Dehydrative deamination (PLP-dependent catalysis), Competitive inhibition (by L-cysteine, D-serine, L-threonine), Noncompetitive inhibition (by homocysteine), Regulation by hormonal signals (insulin/epinephrine inhibit, glucagon upregulates)

03

Biological functions

L-serine catabolic processThreonine catabolic processAmino acid metabolismGluconeogenesis
04

Disease associations

CancerMetabolic disorder (possible relevance in hyperglycemia/tumor biology)Other
05

Safety considerations

Limited understanding of human function; possible metabolic dysregulation with altered activity; no direct evidence of drug toxicity but inhibitors impact major amino acid pathways
06

Interacting drugs

Pyridoxal phosphate (cofactor)

4 more in the full profile.

Beyond the preview

Go deeper on Serine dehydratase-like (SDSL).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Serine dehydratase-like (SDSL).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call